"Paint on" contrast agent puts cancer in focus
This article was originally published in Clinica
Noninvasive, high resolution imaging of cancer cells in vivo could be greatly improved with the development of a new contrast agent that can be literally "painted" onto tissue. The contrast agent could eventually be combined with endoscopy to provide 3-D diagnostic imaging of, for example, the cervix or uterus, a study in Cancer Research (May) suggests.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.